Journals / Meandros Medical And Dental Journal / 2002 / Volume: 3 Issue: 3

Interferon and Lamivudine Combination Therapy in a Child with Chronic Hepatitis B: ACase Report

KRONİK AKTİF HEPATÝT B'Lİ ÇOCUK HASTADA İNTERFERON VE LAMUVİDİN TEDAVİSİ: OLGU SUNUMU

Pages
—
Publication Date
2002-12-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

So we believe that efficiency of this combination must be researched with controlled and extensive studies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:As of today, there is yet no succesful treatment of chronic hepatitis B.
📊
Key Findings & Data:Failure of interferon a-2a treatment for chronic viral hepatitis has prompted combination therapy.
💡
Conclusion & Impact:So we believe that efficiency of this combination must be researched with controlled and extensive studies.
🔬Design:Article
📍Scope:Comprehensive Sample
⚙️Variables:Chronic hepatitis B · interferon -2a · lamivudine

Abstract

As of today, there is yet no succesful treatment of chronic hepatitis B. Failure of interferon a-2a treatment for chronic viral hepatitis has prompted combination therapy. We present a 4 year old male infected with chronic hepatitis B in the replication phase who was treated with a combination of interferon a-2a and lamivudine therapy. Full remission was reached at the end of one year and this affect was still observed after one months of follow-up. So we believe that efficiency of this combination must be researched with controlled and extensive studies.

Özet

-

🔖

Cite This Article

Sönmez, F., Ünüvar, T., İnan, G., Türkmen, M., Öztürk, A., Dikicioğlu, E. (2002). Interferon and Lamivudine Combination Therapy in a Child with Chronic Hepatitis B: ACase Report. Meandros Medical And Dental Journal, Volume: 3 Issue: 3. https://ajindex.com/articles/1291434

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Çakaloðlu Y, Ökten A. Kronik viral hepatitlerde tedavi yaklaþýmlarý 1998Ankara Bilimsel TýpYayýnevi Sayfa: 26-51.
  2. Pessoa MG, Wright TL. Update on clinical trials in the treatment of hepatitis B. J Gastroenterol Hepatol 1999;14 Suppl: 6-11.
  3. Schalm SW, Heathcote J, Cianciara J et al. Lamivudin and alpha interferon combination treatment of patients with chronic hepatitis B infection:a randomised trial. Gut 2000;46: 562-8.
  4. Farrel G. Hepatitis B antigen seroconversion effects of lamivudine alone or in combination with interferon alpha. J Med Virol 2000;6: 374-9.
  5. Mutimer D, Naoumov Nhonkoop P et al. Combination alpha-interferon and lamivudine therapy for alphainterferon-rezistant chronic hepatitis B infection: results of a pilot study. J.Hepatol 1998;28: 923-9.
  6. Wong DKH, Cheung AM, O'Rourke K, et al. Effect of alpha interferon treatment in patients with hepatitis B antigen positive chronic hepatitis B. A meta analysis. Ann Intern Med 1993;119: 312-323.
  7. Wong JB, Koff RS, Tine F, Pauker SG. Costeffectiveness of interferon-á 2b treatment for hepatitis B e antigen-positive chronic hepatitis B. Ann Intern Med 1995;122: 664-675.
  8. Janssen HL, Gerken G, Carreno V et al. Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology 1999;30: 238-43.
  9. Lau DT, Everhart C, Kleiner DE et al. Long-term Follow-up of patients with chronic hepatitis B treated with interferon alfa. Gastroenterology 1997; 113: 1660-7.
  10. Rumi M, Romeo R, de Filippi F et al. A multicentre randomized clinical trial of recombinant alpha-2a interferon therapy in patients with chronic hepatitis B. Ital J Gastroenterol 1993;2:117-20.
  11. Dusheiko G, Lamivudine of chronic hepatitis B. Rev Med Virol 1998;8: 153-159.
  12. Dienstag Jl,Schiff ER,Wright TL et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999;341: 1256-63.
  13. Lai CL, Chien RN, Leung NW et al. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med 1998; 339: 61-8.
  14. Dusheiko G, Lamivudine of chronic hepatitis B. Rev Med Virol 1998;8: 153-159.
  15. Lai CL, Chien RN, Leung NW et al. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med 1998; 339: 61-8.